Patents by Inventor Derek G. Moore

Derek G. Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6458377
    Abstract: A dry composition of an ionophore antibiotic such as monensin comprising from 10 to 95% (when expressed as the sodium salt) of at least one crystalline ionophore antibiotic, from 0 to 10% antifoam agent(s), from 0.1 to 20% wetting and/or surfactant agent(s), from 0.1 to 10% dispersal agent(s), and from 0.1 to 20% suspension agent(s). The use of the composition is as a suspension in water alone or in conjunction with a milk replacer composition and/or a milk extender composition in water as a calf feed composition.
    Type: Grant
    Filed: October 18, 2001
    Date of Patent: October 1, 2002
    Assignee: Eli Lilly and Company
    Inventors: Lionel B. Lowe, Derek G. Moore
  • Publication number: 20020051809
    Abstract: A dry composition of an ionophore antibiotic such as monensin comprising
    Type: Application
    Filed: October 18, 2001
    Publication date: May 2, 2002
    Inventors: Lionel Barry Lowe, Derek G. Moore
  • Patent number: 6365174
    Abstract: A wettable powder composition of crystalline monensin comprising from 90 to 95% (when expressed as the sodium salt) of crystalline monensin from 0.1 to 2% antifoam agent, from 0.1 to 5% wetting agent, from 0.1 to 5% dispersal agent, and from 0.1 to 5% suspension agent. The use of the composition is as a suspension in water alone or in conjunction with a milk replacer composition or a milk extender composition in water as a calf feed composition.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: April 2, 2002
    Assignee: Eli Lilly and Company
    Inventors: Lionel B. Lowe, Derek G. Moore
  • Publication number: 20020031541
    Abstract: A dry composition of an ionophore antibiotic such as monensin comprising from 10 to 95% (when expressed as the sodium salt) of at least one crystalline ionophore antibiotic, from 0 to 10% antifoam agent(s), from 0.
    Type: Application
    Filed: December 18, 1998
    Publication date: March 14, 2002
    Inventors: LIONEL B. LOWE, DEREK G. MOORE